Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1547307

	registered interest
	date	01/12/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an estimate of the number of vacancies there are for (a) nurses and (b) pharmacists in homecare medicines services as of 1 December 2022; and if he will make an assessment of the potential impact of the number of vacancies on (i) the performance of homecare medicines services and (ii) patient safety.
	tabling member constituency	Enfield North
	tabling member printed	Feryal Clark
	uin	101081
	answer	answer is ministerial correction date of answer 22/12/2022 answer text <p>In England there are 12 providers of homecare medicines and services. NHS England (NHSE) have advised they do not collect data on the number of vacancies for nurses and pharmacists in homecare medicines services.</p><p>Homecare providers are assessed on a monthly basis against their Key Performance Indicators (KPIs) at a national level for NHSE framework agreements and at a regional level for NHS regional contracting and more formally on a regular basis through face-to-face meetings with the National Homecare Medicines Committee and NHSE. The level of vacancies do not form part of this quality assurance and governance process, so estimates cannot reasonably be made. The quality assurance and governance process covers the monitoring of patients’ adverse events, complaints and incidents. Providers not meeting their KPIs in these areas are held to account and action is taken to ensure that levels of service are brought back in line with the relevant professional standards, these resolutions impact directly on service performance and patient safety.</p> answering member constituency Colchester answering member printed Will Quince question first answered 22/12/2022 11:55:40 answering member 4423 label Biography information for Will Quince
	tabling member	4822 label Biography information for Feryal Clark

1547308

	registered interest
	date	01/12/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has taken recent steps to help ensure that there are interoperable prescribing systems between NHS providers and homecare medicines services providers.
	tabling member constituency	Enfield North
	tabling member printed	Feryal Clark
	uin	101082
	answer	answer is ministerial correction date of answer 13/12/2022 answer text <p>The National Homecare Medicines Committee’s standardisation programme includes a project with the National Health Service, NHS Digital, Electronic Prescribing and Medicines Administration systems’ vendors and homecare providers to produce a specification for an electronic prescribing system. This will focus on the technical aspects of homecare requirements and will include interoperable prescribing systems.</p> answering member constituency Colchester answering member printed Will Quince question first answered 13/12/2022 16:51:03 answering member 4423 label Biography information for Will Quince
	tabling member	4822 label Biography information for Feryal Clark

1149879

	registered interest
	date	16/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what his policy is on compassionate use programmes that allow the use of an unauthorised medicine.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	1014
	answer	answer is ministerial correction date of answer 25/10/2019 answer text <p>In the United Kingdom, there are currently arrangements in place for unlicensed medicines to be provided that are either manufactured in the UK or imported into the UK under a notification scheme. The national provisions are set out in the Human Medicines Regulations 2012 (Statutory Instrument 2012/1916). Sponsor companies may set up compassionate use programmes under the direction of a prescribing physician for specific patients.</p><p>Where an unmet need has been identified, the Early Access to Medicines Scheme run by the Medicines and Healthcare products Regulatory Agency also provides opportunity for supply of medicines awaiting a licence. These are to be prescribed under the responsibility of the treating physician, supported by a published scientific opinion that has been considered by the Commission on Human Medicines.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 25/10/2019 13:03:48 answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	4056 label Biography information for Nic Dakin

1149902

	registered interest
	date	16/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent steps he has taken to ensure the adequacy of the provision of essential medicines in the event that the UK leaves the EU on 31 October 20109.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	1028
	answer	answer is ministerial correction date of answer 24/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, once we have left the EU.</p><p>The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 24/10/2019 14:19:18 answering member 4362 label Biography information for Edward Argar
	tabling member	4131 label Biography information for Jim Shannon

1548486

	registered interest
	date	05/12/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether (a) the National Homecare Medicines Committee and (b) NHS England has taken steps to help ensure that homecare medicines services providers return to contractual levels of service standards in the last two years.
	tabling member constituency	Enfield North
	tabling member printed	Feryal Clark
	uin	103007
	answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>NHS England’s Commercial Medicines Unit holds regular supplier review meetings with contracted homecare providers every three months. Homecare providers are assessed on a monthly basis against Key Performance Indicators (KPIs). Providers which do not meet the KPIs are held to account and through stakeholder meetings, reporting metrics and face to face meetings, NHS England ensures that levels of service are returned to the relevant professional standards.</p><p>In addition, the National Homecare Medicines Committee (NHMC) holds regular meetings with all homecare providers, focusing on the national KPIs. Where these KPIs or service levels do not meet the relevant standards, the NHMC enacts an escalation process. This process requires the affected homecare provider to communicate with each affected National Health Service organisation with a summary of issues, mitigations and expected timescales for recovery. If necessary, the Care Quality Commission and the General Pharmaceutical Council are also informed. The NHMC has confirmed that this escalation process has been enacted on several occasions in the past two years.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/12/2022 11:59:58 answering member 4423 label Biography information for Will Quince
	tabling member	4822 label Biography information for Feryal Clark

1314651

	registered interest
	date	13/05/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the annual cost to the NHS of mandating the disposal of all unused returned drugs; and what assessment his Department has made of the feasibility of the NHS re-prescribing unused returned drugs instead.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	1050
	answer	answer is ministerial correction date of answer 19/05/2021 answer text <p>The NHS had since taken a range of further measures to further optimise the use of medicines and reduce wastage.</p><p>Medicines cannot normally be reused as the quality of returned medicines cannot be assessed on physical inspection alone. The World Health Organization’s guidelines state that if the quality of an item is unacceptable in the donor country, it is also unacceptable as a donation. Moreover, there are patent issues involved in donating medicines to other countries.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 1051 question first answered 19/05/2021 15:16:52 answering member 4380 label Biography information for Jo Churchill
	tabling member	4079 label Biography information for Julian Sturdy

1314652

	registered interest
	date	13/05/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the feasibility of donating unused returned prescribed drugs to developing countries as part of UK aid projects.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	1051
	answer	answer is ministerial correction date of answer 19/05/2021 answer text <p>The NHS had since taken a range of further measures to further optimise the use of medicines and reduce wastage.</p><p>Medicines cannot normally be reused as the quality of returned medicines cannot be assessed on physical inspection alone. The World Health Organization’s guidelines state that if the quality of an item is unacceptable in the donor country, it is also unacceptable as a donation. Moreover, there are patent issues involved in donating medicines to other countries.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 1050 question first answered 19/05/2021 15:16:52 answering member 4380 label Biography information for Jo Churchill
	tabling member	4079 label Biography information for Julian Sturdy

1550571

	registered interest
	date	12/12/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when his Department last assessed the essential medicines buffer stock to ensure it has the (a) appropriate products and (b) adequate volume of those products.
	tabling member constituency	Ilford North
	tabling member printed	Wes Streeting
	uin	108288
	answer	answer is ministerial correction date of answer 22/12/2022 answer text <p>The Essential Medicines Buffer Stock (EMBS) programme formally ended in 2019/2020. A small number of products were, however, retained in the EMBS to March 2022 as part of the COVID-19 Supportive Medicines stockpile. There are no plans to reinstate the EMBS.</p><p>We are taking decisive action to address temporary supply issues with some antibiotics that can be used to treat Strep A and to improve access to these medicines by continuing to work with manufacturers and wholesalers to speed up deliveries, bring forward stock they have to help ensure it gets to where it is needed and to boost supply to meet demand as quickly as possible.</p><p>Further, Serious Shortage Protocols have been issued across the United Kingdom for penicillin medicines, which will help mitigate local supply issues and allow pharmacists to supply alternative forms of the medicine, or alternative antibiotics, if they don’t have the specific product stated on the prescription.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 108287 question first answered 22/12/2022 11:44:16 answering member 4423 label Biography information for Will Quince previous answer version 43405 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4504 label Biography information for Wes Streeting

1551699

	registered interest
	date	14/12/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether the quality assurance and governance processes set out in contracts for homecare medicines service in England include as key performance indicators for monthly performance assessment the number of (a) delayed deliveries, (b) delayed treatment initiations and (c) missed doses.
	tabling member constituency	Kingston upon Hull West and Hessle
	tabling member printed	Emma Hardy
	uin	110814
	answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>Homecare providers are assessed on a monthly basis against national Key Performance Indicators (KPIs) for National Health Service framework agreements and regionally for local contracting. Regular formal assessments are made through face-to-face meetings with the National Homecare Medicines Committee (NHMC) and NHS England. These KPIs include delayed deliveries and missed doses.</p><p>When KPIs or NHS hospitals report that service levels do not meet the relevant standards, the NHMC enacts an escalation process. Where this process is in place, the affected homecare provider will provide each NHS organisation with a summary of the issues, mitigations and expected timescales for recovery. If necessary, the Care Quality Commission and the General Pharmaceutical Council are also informed.</p><p>The National Clinical Homecare Association is working with the British Society for Rheumatology to arrange discussions with its members, the NHMC and NHS England regarding the safety and performance of the Homecare Medicine Delivery Service.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 110815 question first answered 20/12/2022 11:40:12 answering member 4423 label Biography information for Will Quince previous answer version 43396 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4645 label Biography information for Emma Hardy

1551700

	registered interest
	date	14/12/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what powers NHS England has to hold homecare medicines services providers to account for (a) delayed deliveries, (b) delayed treatment initiation and (c) missed doses of medicines.
	tabling member constituency	Kingston upon Hull West and Hessle
	tabling member printed	Emma Hardy
	uin	110815
	answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>Homecare providers are assessed on a monthly basis against national Key Performance Indicators (KPIs) for National Health Service framework agreements and regionally for local contracting. Regular formal assessments are made through face-to-face meetings with the National Homecare Medicines Committee (NHMC) and NHS England. These KPIs include delayed deliveries and missed doses.</p><p>When KPIs or NHS hospitals report that service levels do not meet the relevant standards, the NHMC enacts an escalation process. Where this process is in place, the affected homecare provider will provide each NHS organisation with a summary of the issues, mitigations and expected timescales for recovery. If necessary, the Care Quality Commission and the General Pharmaceutical Council are also informed.</p><p>The National Clinical Homecare Association is working with the British Society for Rheumatology to arrange discussions with its members, the NHMC and NHS England regarding the safety and performance of the Homecare Medicine Delivery Service.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 110814 question first answered 20/12/2022 11:40:12 answering member 4423 label Biography information for Will Quince previous answer version 43419 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
	tabling member	4645 label Biography information for Emma Hardy